Mylan NV was hit Monday with a lawsuit alleging the drug company overcharged EpiPen patients as part of an illegal scheme to secure sales. The lawsuit, which is seeking class-action status, is the ...

Pharmaceutical company gains 4.6 percent stake in rival. Teva Pharmaceutical Industries Ltd. has acquired a 4.61 percent stake in generic drug rival Mylan N.V., giving Teva standing to challenge ...